GC
BNGO icon

GMT Capital’s Bionano Genomics BNGO Stock Holding History

GMT Capital’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-8,838
Closed -$241K – 60
2024
Q3 		$241K Hold
8,838
– – 0.01% 68
2024
Q2 		$360K Buy
+8,838
New +$486K 0.01% 60
2024
Q1 		– Sell
-8,838
Closed -$1M – 55
2023
Q4 		$1M Hold
8,838
– – 0.04% 45
2023
Q3 		$1.61M Buy
+8,838
New +$2.32M 0.06% 75

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

GMT Capital's BNGO Position: Q4 2024 in Review

GMT Capital sold out of Bionano Genomics (BNGO) in Q4 2024, closing a stake of 8,838 shares — an estimated $241K sold.

GMT Capital first reported a position in BNGO in Q3 2023 and held it in 4 quarters. The position peaked at $1.61M in Q3 2023. 50 funds tracked by Wall St. Rank hold BNGO as of Q4 2024.

  • GMT Capital reported no remaining Bionano Genomics position as of Q4 2024 after selling out during the quarter.
  • GMT Capital sold 8,838 Bionano Genomics shares in Q4 2024, an estimated $241K.
  • GMT Capital first reported a position in Bionano Genomics in Q3 2023 and held it in 4 quarters.
  • GMT Capital's Bionano Genomics position peaked at $1.61M in Q3 2023.
  • 50 funds tracked by Wall St. Rank held Bionano Genomics as of Q4 2024.

Based on GMT Capital's 13F filing for Q4 2024, filed 14 Feb 2025.